CytoDyn (CYDY) Non Operating Interest Expenses (2012 - 2026)
Powered by 
Analysis
CytoDyn (CYDY) Non Operating Interest Expenses (2012 - 2026) Analysis & Trends
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Non Operating Interest Expenses (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.76 Bn | 131.91 Bn | 2.84 Bn | - |
| 2 | Regeneron Pharmaceuticals | 85.72 Bn | 77.72 Bn | 3.93 Bn | 11.00 Mn |
| 3 | Argenx Se | 63.56 Bn | 58.38 Bn | 1.37 Bn | -1.00 Mn |
| 4 | Moderna | 57.87 Bn | 52.73 Bn | 52.00 Mn | - |
| 5 | Revolution Medicines | 44.06 Bn | 44.06 Bn | - | 23.78 Mn |
| 6 | BeOne Medicines | 40.08 Bn | 34.98 Bn | 1.53 Bn | 39.74 Mn |
| 7 | Alnylam Pharmaceuticals | 35.50 Bn | 32.20 Bn | 992.69 Mn | 82.05 Mn |
| 8 | Royalty Pharma | 28.54 Bn | 27.70 Bn | - | 93.62 Mn |
| 9 | Insmed | 27.49 Bn | 26.33 Bn | 358.27 Mn | 20.27 Mn |
| 10 | CytoDyn | 263.02 Mn | 263.02 Mn | - | 555,000.00 |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| May 31, 2026 | 555,000.00 |
| Feb 28, 2026 | 614,000.00 |
| Nov 30, 2025 | 644,000.00 |
| Aug 31, 2025 | 676,000.00 |
| May 31, 2025 | 955,000.00 |
| Feb 28, 2025 | 1.14 Mn |
| Nov 30, 2024 | 1.16 Mn |
| Aug 31, 2024 | 1.17 Mn |
| May 31, 2024 | 1.15 Mn |
| Feb 29, 2024 | 1.15 Mn |
| Nov 30, 2023 | 1.16 Mn |
| Aug 31, 2023 | 1.20 Mn |
| May 31, 2023 | 14.86 Mn |
| Feb 28, 2023 | 9.78 Mn |
| Nov 30, 2022 | 3.33 Mn |
| Aug 31, 2022 | 11.28 Mn |
| May 31, 2022 | 5.07 Mn |
| Feb 28, 2022 | 21.89 Mn |
| Nov 30, 2021 | 14.76 Mn |
| Aug 31, 2021 | 23.70 Mn |